FDA Status
Not FDA-Approved
Phase 3 TRIUMPH trials actively ongoing (2026)
Claimed Benefits
- Obesity & weight loss (24.2% at 48 weeks)
- Type 2 diabetes glycemic control
- Fatty liver disease resolution
- Appetite suppression
Clinical Evidence
5
Human Trials
Phase III
Highest Phase
12mg dose produced 24.2% mean body weight reduction at 48 weeks, among the highest ever recorded in a clinical obesity trial.
Read Full Deep Dive
Mechanism, dosing, vendor pricing, and full research citations